3rd Quarter - Report

NVG, LLC for ALEXION PHARMACEUTICALS

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Intellectual property and potential changes to the patent system, generally

LobbyistCovered position, as disclosed
ANDREA LARUE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

FDA - rare and orphan disease issues; H.R. 6, 21st Century CURES Act; Prescription drug coverage and payment policies; Medical innovation issues; Medicaid coverage for orphan drugs; H.R. 1537, Advancing Hope Act of 2015; S. 1878, Advancing Hope Act of 2016

LobbyistCovered position, as disclosed
LISA GERMAN FOSTER —
PATRICIA GRIFFIN —
ANDREA LARUE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1537 (114th), H.R. 6 (114th), S. 1878 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.